MSM (methylsulfonylmethane) is an organosulfur compound sold as a joint-support ingredient, usually alongside glucosamine or chondroitin. Unlike most ingredients in this category, it is dosed in grams rather than milligrams, which changes how a product has to be built.
This guide is for brand owners planning an MSM product made in Japan. It covers what the human trials show at different doses, MSM’s food status, how gram-level dosing shapes the format, and what to fix before asking for a quotation.
Health supplements are foods, not medicines, and are not a substitute for medical treatment. Nothing here is a claim that any product prevents, treats or cures a disease.
💬 Planning an MSM product made in Japan? We check the full formula against Japanese food law first. See Japan-made supplement OEM.
What the research shows
Small randomised trials of MSM report mixed results that appear to depend on dose and population — a low dose in healthy trainees showed no benefit, while higher doses in adults with knee osteoarthritis showed partial or full improvement.
| Study | Design | Reported result |
|---|---|---|
| Randomised, placebo-controlled trial, US Army Medical Department Journal 2017;(3-17):21–25 (PMID 29214616) | 180 healthy military trainees; MSM 3 g/day for 8 weeks, to test prevention of knee pain | No significant improvement in knee-related or mood outcome scores at 30 or 60 days versus placebo |
| Randomised controlled study, BMC Complementary and Alternative Medicine 2011;11:50 (PMID 21708034) | 49 adults with knee osteoarthritis; MSM 1.125 g three times daily (3.375 g/day) for 12 weeks | Significant improvement in physical function and total WOMAC score versus placebo; pain and stiffness subscores did not reach significance; authors described the improvements as small |
| Randomised, double-blind, placebo-controlled trial, Nutrients 2023;15(13):2995 (PMC10346176) | 80 adults with mild knee pain; MSM 2 g/day (ten 200 mg tablets) for 12 weeks | Significantly lower knee-related symptom score (JKOM) at 12 weeks than placebo, with improvements in morning, nocturnal and standing pain; no adverse events reported |
Three points to keep in view:
- Dose varies widely between trials — 2 g, 3 g and 3.375 g/day, none directly compared against each other. A result at one dose should not be assumed to apply to another.
- Not every trial was positive. The 8-week, 3 g/day trial in healthy trainees found no significant benefit. Report that alongside the positive results, not instead of them.
- Funding. The 2023 trial was funded by an ingredient manufacturer. Read the funding line of any study you plan to cite.
- Population. The 2011 trial studied adults with diagnosed knee osteoarthritis. That is a fact about the research population, not something to carry into a product claim.
Checked against the published abstracts on 25 September 2026.
What Japanese products say
MSM has been treated by Japan’s health ministry as a food ingredient, rather than a medicine, since 2001, provided no medicinal effect is claimed for it.
This status lets MSM be sold as a food-form ingredient in Japan, in the same way as many other organosulfur or amino-acid-type ingredients placed on the same kind of list. It is a food-status classification, not a notified function claim, so any specific joint-related wording on a Japanese product still needs its own supporting evidence and its own route to market, such as the Foods with Function Claims system.
💬 Need an evidence summary for your regulatory adviser that separates the dose levels above? We prepare it with the manufacturing documents. Tell us your market.
Wording that stays on safe ground
Describe MSM by the dose and outcome studied, never by a disease it would treat.
| Safer wording | Wording to avoid |
|---|---|
| ”Studied for knee joint comfort and physical function” | Names of joint diseases, or “treats” or “reverses” arthritis |
| ”Contains 2,000 mg MSM per daily serving" | "Clinically proven” without naming the study, its dose and its limits |
| Naming the dose alongside the study you cite | Implying every dose of MSM gives the same result |
How MSM is formulated
Trial doses run from 2 to 3.375 grams a day, which is too much for a single small tablet, so MSM products are usually multiple tablets or a powder.
| Dosage form | Why brands choose it | What to weigh up |
|---|---|---|
| Multiple tablets or capsules per serving | Matches gram-level trial doses without an oversized single unit | A single tablet realistically holds well under 1 g of active ingredient at a practical size, so 2–3.375 g/day usually means several units |
| Powder or powder stick | Delivers the full gram-level dose in one serving | Taste; MSM has a mild sulfurous taste that needs masking |
| Combined joint formula | Paired with glucosamine or chondroitin at their own gram-level doses | Total tablet or capsule count per serving can grow quickly |
Decisions that shape the specification:
- Dose. Match the amount to the study you intend to cite — for example 2 g/day for the 2023 trial or 3.375 g/day for the 2011 trial. These are not interchangeable claims.
- Format. Decide early whether the gram-level dose will be several tablets, a powder stick, or split across the day, since this shapes packaging and instructions for use.
- Companion ingredients. MSM is commonly combined with glucosamine, chondroitin or collagen. Each needs its own check against Japanese food law and its own dose rationale.
- Your market’s status for MSM. Confirm its status as a food ingredient in your target markets before you commit to a formula.
The check that comes first
Every ingredient must be permitted in foods in Japan, or a Japanese factory cannot make the product.
MSM itself has been treated as a food ingredient in Japan since 2001. Companion ingredients in a combined joint formula are where a check most often turns up a problem. See the Japan-made supplement OEM page, and compare with our glucosamine and chondroitin guides if you plan a combined formula.
Before you ask for a quotation
A factory can quote accurately once the dose, the format, the companions and the packaging are fixed.
- MSM amount per day and how it is split across tablets, capsules or a powder serving
- Dosage form and flavour if powder
- Companion ingredients and their amounts
- Packaging
- Countries you will sell in, and MSM’s status there
- First order and annual volume
💬 Ready to design a Japan-made MSM product? Send us the concept — dose, format, companion ingredients and the countries you will sell in.
Frequently asked questions
1. Does MSM help with knee joints?
Results are mixed and appear to depend on dose. A 2023 trial found improvement at 2 g/day in adults with mild knee pain, and a 2011 trial found improvement in physical function (but not pain or stiffness) at 3.375 g/day in adults with knee osteoarthritis. An 8-week trial at 3 g/day in healthy military trainees found no significant benefit.
2. Why is MSM dosed in grams instead of milligrams?
Because that is the dose range used in the human trials, typically 2 to 3.375 g a day. A single tablet cannot realistically hold that much active ingredient, so MSM products are usually several tablets or a powder serving.
3. Is MSM legal to sell as a food ingredient in Japan?
Japan’s health ministry has treated MSM as a food ingredient, rather than a medicine, since 2001, provided no medicinal effect is claimed for it.
4. Who funds MSM research?
At least one of the trials reviewed here was funded by an ingredient manufacturer. Check the funding statement of any study you cite.
5. Can MSM be combined with glucosamine or chondroitin?
Yes, this is a common combination. Each ingredient still needs its own check against Japanese food law and its own dose rationale.
Sources: “A randomized controlled trial evaluating methylsulfonylmethane versus placebo to prevent knee pain in military initial entry trainees”, US Army Medical Department Journal 2017;(3-17):21–25 (PMID 29214616); “Efficacy of methylsulfonylmethane supplementation on osteoarthritis of the knee: a randomized controlled study”, BMC Complementary and Alternative Medicine 2011;11:50 (PMID 21708034); “Methylsulfonylmethane Improves Knee Quality of Life in Participants with Mild Knee Pain: A Randomized, Double-Blind, Placebo-Controlled Trial”, Nutrients 2023;15(13):2995 (PMC10346176). Checked on 25 September 2026.